| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 329.656 | 316.709 | 510.606 | 507.492 |
| Total Income - EUR | - | - | - | - | - | - | 329.671 | 317.063 | 510.825 | 507.664 |
| Total Expenses - EUR | - | - | - | - | - | - | 234.498 | 245.197 | 434.067 | 425.073 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 95.172 | 71.866 | 76.758 | 82.591 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 91.942 | 69.036 | 72.092 | 68.799 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Solantis Laboratory S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 29.008 | 22.553 |
| Current Assets | - | - | - | - | - | - | 174.331 | 129.027 | 127.189 | 184.395 |
| Inventories | - | - | - | - | - | - | 18.951 | 19.139 | 15.578 | 8.858 |
| Receivables | - | - | - | - | - | - | 11.682 | 45.134 | 22.195 | 86.520 |
| Cash | - | - | - | - | - | - | 143.698 | 64.754 | 89.415 | 89.017 |
| Shareholders Funds | - | - | - | - | - | - | 91.982 | 69.085 | 105.550 | 68.848 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 82.349 | 60.112 | 51.081 | 138.662 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Solantis Laboratory S.r.l.